{"schema_version":"secwatch.filing_event.v1","accession":"0001356576-25-000046","form_type":"8-K","ticker":"SUPN","cik":"0001356576","company_name":"SUPERNUS PHARMACEUTICALS, INC.","filed_at":"2025-07-22T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.806585+00:00","generated_at":"2026-05-18T04:12:20.504666+00:00","sec_items":["2.02","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Supernus announces Q2 2025 earnings release and conference call on Aug 5, 2025","bullets":["Press release states Q2 2025 results will be reported after market close on August 5, 2025.","Conference call with President/CEO Jack Khattar and CFO Tim Dec on August 5 at 4:30 p.m. ET.","No preliminary financial results or guidance are provided in this announcement."],"urls":{"canonical":"https://secwatch.observer/filing/0001356576-25-000046","json":"https://secwatch.observer/filing/0001356576-25-000046.json","markdown":"https://secwatch.observer/filing/0001356576-25-000046.md","text":"https://secwatch.observer/filing/0001356576-25-000046.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1356576/000135657625000046/0001356576-25-000046-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1356576/000135657625000046/supn-20250722.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T04:12:20.504666+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}